Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have enzyme binding activity; identical protein binding activity; and tumor necrosis factor receptor binding activity. Predicted to be involved in several processes, including positive regulation of NF-kappaB transcription factor activity; protein K63-linked ubiquitination; and regulation of signal transduction. Predicted to localize to cytoplasmic side of plasma membrane and plasma membrane signaling receptor complex. Is expressed in jaw and urinary system. Orthologous to human TRAF1 (TNF receptor associated factor 1).